Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells

LaMonica V. Stewart, Besstina Lyles, Ming-Fong Lin, Nancy L. Weigel

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We have previously shown that concentrations of 1α,25- dihydroxyvitamin D3 (1,25D) that induce G0/G1 cell cycle arrest in androgen-dependent LNCaP prostate cancer cells also decrease expression of c-Myc, a proto-oncogene that stimulates progression from G1 to S phase of the cell cycle. Since both c-Myc expression and cell cycle progression are regulated by tyrosine kinase activation, we examined the ability of 1,25D to alter tyrosine kinase signaling in LNCaP cells and the androgen-independent LNCaP C81 (C81 LN) cell line. 1,25D selectively reduced protein tyrosine phosphorylation within both the LNCaP and C81 LN cells. This reduction in tyrosine kinase signaling appears to result from elevated levels of cellular prostatic acid phosphatase (PAcP). Western blots and biochemical assays revealed 1,25D increases the level of active PAcP in both cell lines. In addition, 1,25D decreased tyrosine phosphorylation of HER-2, an EGFR family member inactivated by PAcP, and the HER-2 downstream adaptor protein p52 Shc in C81 LN cells. Inhibition of HER-2 signaling by AG825 reduces growth of C81 LN cells and the parental LNCaP cells. These data therefore suggest that 1,25D-mediated decreases in LNCaP and C81 LN cell growth are in part due to decreases in tyrosine kinase signaling that result from up-regulation of PAcP.

Original languageEnglish (US)
Pages (from-to)37-46
Number of pages10
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume97
Issue number1-2
DOIs
StatePublished - Oct 1 2005

Fingerprint

Calcitriol Receptors
Calcitriol
Cell growth
Prostatic Neoplasms
Cells
Protein-Tyrosine Kinases
Growth
Phosphorylation
Androgens
Tyrosine
Shc Signaling Adaptor Proteins
Cell Cycle
G1 Phase Cell Cycle Checkpoints
Cell Line
myc Genes
Aptitude
prostatic acid phosphatase
S Phase
Assays
Proteins

Keywords

  • HER-2
  • Prostate cancer
  • Prostatic acid phosphatase
  • Vitamin D

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. / Stewart, LaMonica V.; Lyles, Besstina; Lin, Ming-Fong; Weigel, Nancy L.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 97, No. 1-2, 01.10.2005, p. 37-46.

Research output: Contribution to journalArticle

@article{5d1ed2592f194b4395aa9c10133cdeb2,
title = "Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells",
abstract = "We have previously shown that concentrations of 1α,25- dihydroxyvitamin D3 (1,25D) that induce G0/G1 cell cycle arrest in androgen-dependent LNCaP prostate cancer cells also decrease expression of c-Myc, a proto-oncogene that stimulates progression from G1 to S phase of the cell cycle. Since both c-Myc expression and cell cycle progression are regulated by tyrosine kinase activation, we examined the ability of 1,25D to alter tyrosine kinase signaling in LNCaP cells and the androgen-independent LNCaP C81 (C81 LN) cell line. 1,25D selectively reduced protein tyrosine phosphorylation within both the LNCaP and C81 LN cells. This reduction in tyrosine kinase signaling appears to result from elevated levels of cellular prostatic acid phosphatase (PAcP). Western blots and biochemical assays revealed 1,25D increases the level of active PAcP in both cell lines. In addition, 1,25D decreased tyrosine phosphorylation of HER-2, an EGFR family member inactivated by PAcP, and the HER-2 downstream adaptor protein p52 Shc in C81 LN cells. Inhibition of HER-2 signaling by AG825 reduces growth of C81 LN cells and the parental LNCaP cells. These data therefore suggest that 1,25D-mediated decreases in LNCaP and C81 LN cell growth are in part due to decreases in tyrosine kinase signaling that result from up-regulation of PAcP.",
keywords = "HER-2, Prostate cancer, Prostatic acid phosphatase, Vitamin D",
author = "Stewart, {LaMonica V.} and Besstina Lyles and Ming-Fong Lin and Weigel, {Nancy L.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.jsbmb.2005.06.011",
language = "English (US)",
volume = "97",
pages = "37--46",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "1-2",

}

TY - JOUR

T1 - Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells

AU - Stewart, LaMonica V.

AU - Lyles, Besstina

AU - Lin, Ming-Fong

AU - Weigel, Nancy L.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - We have previously shown that concentrations of 1α,25- dihydroxyvitamin D3 (1,25D) that induce G0/G1 cell cycle arrest in androgen-dependent LNCaP prostate cancer cells also decrease expression of c-Myc, a proto-oncogene that stimulates progression from G1 to S phase of the cell cycle. Since both c-Myc expression and cell cycle progression are regulated by tyrosine kinase activation, we examined the ability of 1,25D to alter tyrosine kinase signaling in LNCaP cells and the androgen-independent LNCaP C81 (C81 LN) cell line. 1,25D selectively reduced protein tyrosine phosphorylation within both the LNCaP and C81 LN cells. This reduction in tyrosine kinase signaling appears to result from elevated levels of cellular prostatic acid phosphatase (PAcP). Western blots and biochemical assays revealed 1,25D increases the level of active PAcP in both cell lines. In addition, 1,25D decreased tyrosine phosphorylation of HER-2, an EGFR family member inactivated by PAcP, and the HER-2 downstream adaptor protein p52 Shc in C81 LN cells. Inhibition of HER-2 signaling by AG825 reduces growth of C81 LN cells and the parental LNCaP cells. These data therefore suggest that 1,25D-mediated decreases in LNCaP and C81 LN cell growth are in part due to decreases in tyrosine kinase signaling that result from up-regulation of PAcP.

AB - We have previously shown that concentrations of 1α,25- dihydroxyvitamin D3 (1,25D) that induce G0/G1 cell cycle arrest in androgen-dependent LNCaP prostate cancer cells also decrease expression of c-Myc, a proto-oncogene that stimulates progression from G1 to S phase of the cell cycle. Since both c-Myc expression and cell cycle progression are regulated by tyrosine kinase activation, we examined the ability of 1,25D to alter tyrosine kinase signaling in LNCaP cells and the androgen-independent LNCaP C81 (C81 LN) cell line. 1,25D selectively reduced protein tyrosine phosphorylation within both the LNCaP and C81 LN cells. This reduction in tyrosine kinase signaling appears to result from elevated levels of cellular prostatic acid phosphatase (PAcP). Western blots and biochemical assays revealed 1,25D increases the level of active PAcP in both cell lines. In addition, 1,25D decreased tyrosine phosphorylation of HER-2, an EGFR family member inactivated by PAcP, and the HER-2 downstream adaptor protein p52 Shc in C81 LN cells. Inhibition of HER-2 signaling by AG825 reduces growth of C81 LN cells and the parental LNCaP cells. These data therefore suggest that 1,25D-mediated decreases in LNCaP and C81 LN cell growth are in part due to decreases in tyrosine kinase signaling that result from up-regulation of PAcP.

KW - HER-2

KW - Prostate cancer

KW - Prostatic acid phosphatase

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=27544436332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544436332&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2005.06.011

DO - 10.1016/j.jsbmb.2005.06.011

M3 - Article

C2 - 16076555

AN - SCOPUS:27544436332

VL - 97

SP - 37

EP - 46

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 1-2

ER -